Evidence map›Paper›PMID 42033894›Full record

Trial reportDrug and alcohol dependence2026

Implementation of addiction consult services and bridge clinics in the HEALing communities study in Massachusetts.

Zoe M Weinstein, Elizabeth Jadovich, Mari-Lynn Drainoni, Marc LaRochelle, Shapei Yan, Jungwun Lee, Amy Bettano, Donna Beers, Alexander Y Walley, Jeffrey H Samet

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zoe M WeinsteinGrayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine Department of Medicine, Boston Medical Center, and the Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States. Electronic address: zoe.weinstein@bmc.org.
Elizabeth JadovichGrayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine Department of Medicine, Boston Medical Center, and the Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Mari-Lynn DrainoniSection of Infectious Diseases, Department of Medicine, Boston Medical Center & Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States; Department of Health Law Policy & Management, Boston University School of Public Health, Boston, MA, United States; Evans Center for Implementation and Improvement Sciences, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Marc LaRochelleGrayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine Department of Medicine, Boston Medical Center, and the Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Shapei YanGrayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine Department of Medicine, Boston Medical Center, and the Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Jungwun LeeDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, United States.
Amy BettanoMassachusetts Department of Public Health, Boston, MA, United States.
Donna BeersGrayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine Department of Medicine, Boston Medical Center, and the Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Alexander Y WalleyGrayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine Department of Medicine, Boston Medical Center, and the Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Jeffrey H SametGrayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine Department of Medicine, Boston Medical Center, and the Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.

Funding

MassHEAL - Reducing overdose deaths by 40% (2019-2023)UM1DA049412 · NIDA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2019 to 2023
$82.9M
HEALing Communities Study Health Equity ResearchUM1DA049394 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI GLASGOW, LASHAWN, OGA, EMMANUEL AJA · 2019 to 2023
$40.6M
NIDA NIH HHS UM1 DA049394NIDA NIH HHS UM1 DA049412
6 · The paper itself

Abstract

introductionAddiction Consult Services (ACS) and bridge clinics are hospital-based intervention strategies to expand access to medication for opioid use disorder (MOUD) which many Massachusetts communities adopted during the HEALing Communities Study (HCS). This study describes the implementation of HCS hospital-based MOUD intervention strategies using the RE-AIM framework.

methodsPost-hoc analysis of community ACS and bridge clinic implementation as part of a waitlist cluster randomized controlled trial of sixteen Massachusetts HCS communities across Wave 1 (randomized to receive intervention first) and Wave 2 (wait-list controls received the intervention second). The intervention was ACS and/or bridge clinics. Main measures include Adoption (planned to implement); Implementation (served at least one patient); Reach (median number of patients served per month); Effectiveness (receipt of MOUD within 14 days of opioid-related emergency or hospital encounter using Massachusetts Public Health Data Warehouse) and Maintenance (serving patients in the year post-study intervention).

resultsEleven communities adopted 17 ACS and bridge clinics. Among the 17 adopted, 14 (7 ACS and 7 bridge clinics) were implemented. ACS reached a median of 16 patients/month and bridge clinics a median of 51 patients/month. Hospitals that implemented ACS and bridge clinics first did not have significantly higher 14-day post hospital MOUD rates compared to waitlisted hospitals. All 14 implemented ACS and bridge clinics were maintained post-intervention.

conclusionsACS and bridge clinics were widely adopted intervention strategies, and the majority of programs were implemented and sustained, demonstrating the perceived value of these services to their communities.

Indexed as

Opiate Substitution TreatmentOpioid-Related DisordersReferral and ConsultationAdultBuprenorphineFemaleHumansMaleMassachusettsMiddle AgedBuprenorphineBuprenorphineConsult serviceMethadoneOpioid use disorder

Identifiers

PMID42033894
PMCPMC13533503

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.